On February 26, 2020 Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the market closes on Friday, February 28, 2020 (Press release, Cellular Biomedicine Group, FEB 26, 2020, View Source [SID1234554836]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company will host a conference call and webcast with the investment community on Friday, February 28th at 4:30 p.m. Eastern Time, featuring remarks by Tony Liu, Executive Director, CEO and CFO of CBMG.
What:
Cellular Biomedicine Fourth Quarter and Full Year 2019 Results Conference Call
Date:
Friday, February 28, 2020
Time:
4:30 p.m. Eastern Time
Live Call:
Toll-Free: 1-877-423-9813
International: 1-201-689-8573
Webcast:
Replay:
Toll-Free: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 13699688
(Available approximately two hours after the completion of the live call until 11:59 p.m. ET on March 13, 2020)